http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0421697-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06
filingDate 1990-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f451316b3501b2f02de9fd5b05bffb2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fac643cba7b45dbe330bf66bf5475c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5efe419d7ae27e6132be0a5fb5f864f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e194166d22eab8861621ae849018eda7
publicationDate 1991-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0421697-A2
titleOfInvention Contrast agents and methods for enhancing magnetic resonance imaging
abstract Chelates of certain paramagnetic metals, particularly ytterbium diethylenetriamine pentaacetic acid (Yb-DTPA), have been found to alter or enhance contrast of magnetic resonance (MR) images by causing susceptibility-­induced spin dephasing in the tissue to be imaged, but causing substantially no dipole-dipole interactions. These contrast agents are particularly useful in monitoring fluid flow using fast imaging sequences, such as gradient echo imaging, particularly glomerular filtration rate (renal clearance) to detect renal pathologies, such as glomerulonephritis, and cerebral blood flow to detect focal blood-brain barrier defects, which could allow early diagnosis of stroke.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008148877-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110702888-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861315-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102176924-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014040580-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008148877-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110702888-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102012018076-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102012018076-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9218874-A1
priorityDate 1989-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8602005-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159324746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160908079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452755931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450514185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577457

Total number of triples: 45.